The stock has experienced significant volatility and a pronounced downtrend over the observed 180-day period. From a peak near $403 in late 2025, the price has fallen to approximately $300.83 as of March 31, 2026, representing a 6-month decline of 3.85% and a more severe 3-month drop of 15.77%.

Short-term performance shows mixed signals; the stock gained 0.65% on the last trading day and is up 14.98% over the past month, indicating a recent rebound from lower levels. However, this positive 1-month move follows a steep correction, as evidenced by the 52-week low of $262.83 and high of $403.58.

Currently, the price of $300.83 sits roughly in the middle of its 52-week range, approximately 18% above the low and 25% below the high. The stock has shown relative strength against the S&P 500 over the past month, outperforming by 5.40 percentage points, but has significantly underperformed over the past year by nearly 24 percentage points.

Revenue and profitability have been volatile on a quarterly basis. Q4 2025 revenue was $4.93 billion, showing strong year-over-year growth of 40.43% compared to Q4 2024. However, net income swung from a loss of $29.5 million in Q3 2025 to a profit of $300.7 million in Q4 2025, with the net margin recovering to 6.1% from negative territory.

Financial health appears mixed. The company maintains a strong current ratio of 2.42, indicating good short-term liquidity. However, the debt-to-equity ratio is elevated at 1.36, suggesting a leveraged balance sheet. Cash flow from operations was positive at $661.9 million in Q4 2025, but trailing twelve-month free cash flow is negative at -$1.10 billion, largely impacted by significant working capital changes and acquisitions.

Operational efficiency metrics show a return on equity (ROE) of 16.15% and a return on assets (ROA) of 5.43%, which are reasonable. The quarterly asset turnover has fluctuated, reaching 0.267 in Q4 2025, indicating the company generates about $0.27 in revenue for every dollar of assets.